Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2024 Earnings Call Transcript
Operator: Good day and welcome to Arcutis Biotherapeutics' 2024 First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Arcutis Biotherapeutics Inc. (ARQT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 7,877,297 | $78,064,013 | -8% | 2.89% |
| 2. | Rubric Capital Management David Rosen | 7,510,000 | $74,424,100 | +14% | 2.19% |
| 3. | Polar Capital Brian Ashford-Russell And Tim Woolley | 6,885,922 | $68,239,487 | +10% | 0.35% |
| 4. | StemPoint Capital Michelle Ross | 2,205,899 | $21,860,459 | -15% | 5.77% |
| 5. | Cormorant Asset Management Bihua Chen | 2,125,000 | $21,058,750 | 0.92% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.50 | 21,052 | 8,785,284 | 2024-03-04 | Filing | ||
| $6.38 | 1,463 | Officer, Director | 515,145 | 2023-05-31 | Filing | |
| $2.50 | 80,000 | Large Shareholder | 8,764,232 | 2023-10-24 | Filing | |
| $20.00 | 250,000 | Large Shareholder | 8,684,232 | 2022-08-05 | Filing | |
| $25.00 | 296,000 | Large Shareholder, Director | 902,286 | 2020-10-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.31 | 10,000 | Director | 180,339 | 2024-07-01 | Filing | |
| $8.01 | 6,458 | Director | 170,200 | 2024-06-04 | Filing | |
| $8.00 | 3,542 | Director | 176,658 | 2024-06-04 | Filing | |
| $8.75 | 23,000 | Officer | 209,793 | 2024-05-30 | Filing | |
| $8.72 | 49,952 | Officer | 209,793 | 2024-05-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,066,082 | $29,283,445 | 0.02% | |
| 2. | 8,764,232 | $28,308,469 | 1.51% | |
| 3. | 6,083,072 | $19,648,324 | 0% | |
| 4. | 5,916,546 | $19,110,443 | 0% | |
| 5. | 4,896,513 | $15,815,736 | 0% |
News See All
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q4 2023 Earnings Call Transcript
Arcutis Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.72 EPS, expectations were $-0.65. Arcutis Biotherapeutics, Inc.
5 High Growth Micro-cap Stocks to Buy
3 Wall Street analysts covered Blade Air Mobility, Inc. (NASDAQ:BLDE) over the last three months, and all kept a Buy rating on the stock.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Arcutis Biotherapeutics Third Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
11 Cheap Small-Cap Stocks to Buy Before the Next Breakout
In this piece, we will take a look at 11 cheap small cap stocks to buy before the next breakout.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Arcutis Biotherapeutics Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
5 Best Short Squeeze Stocks to Buy Now
There was a surge in hedge fund ownership of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) during the third quarter of 2022, as the number of smart money shareholders of the company nearly doubled.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Arcutis Biotherapeutics Q1 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. And welcome to Arcutis Biotherapeutics, Inc. Fourth Quarter 2022 Earnings Conference Call.
10 Small-Cap Stocks to Buy According to Billionaire Steve Cohen
In this article, we discuss the 10 small-cap stocks to buy according to billionaire Steve Cohen.
Billionaire Hedge Funds
